arrow
S

Steven N. Hart

Mayo Clinic
H指数:54
被引数:1.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Partially functional hypomorphic missense variants in BRCA2 are reduced penetrance pathogenic variants

BRCA2基因中部分功能性的半合型错义变异是降低外显率的致病性变异

2026-11-170
OAAI
The CARE framework for AI dataset documentation in clinical laboratories: a comprehensive checklist and data lineage methodology

临床实验室中用于AI数据集文档的CARE框架:一份全面的检查清单和数据谱系方法

2026-05-010
PRE
Susceptibility gene mutations in germline and tumors of patients with HER2-negative advanced breast cancer
2024-07-130
OAAI
Image-based multiplex immune profiling of cancer tissues: translational implications. A report of the International Immuno-oncology Biomarker Working Group on Breast Cancer

基于图像的癌症组织多重免疫分析: 翻译意义。国际乳腺癌免疫肿瘤学生物标志物工作组的报告

2024-01-173
OA
Pitfalls in machine learning-based assessment of tumor-infiltrating lymphocytes in breast cancer: a report of the international immuno-oncology biomarker working group

基于机器学习的乳腺癌肿瘤浸润淋巴细胞评估中的陷阱: 国际免疫肿瘤学生物标志物工作组的报告

2023-08-2312
OAAI
Functional and Clinical Characterization of Variants of Uncertain Significance Identifies a Hotspot for Inactivating Missense Variants in RAD51C

意义不确定的变体的功能和临床表征确定了RAD51C中失活错义变体的热点

2023-05-302
OAAI
Population-based Estimates of contralateral Breast Cancer Risk among Carriers of Germline Pathogenic Variants in ATM, BRCA1, BRCA2, CHEK2, and PALB2
2023-03-011
PRE
Population-based risk estimates of clinical subtypes of breast cancer among carriers of germline pathogenic variants in cancer predisposition genes
2022-02-150
PRE
Mapping molecular subtype specific alterations in breast cancer brain metastases identifies clinically relevant vulnerabilities
2022-01-2650
OAAI
Design considerations for workflow management systems use in production genomics research and the clinic
2021-11-0410
OAAI
A Population-Based Study of Genes Previously Implicated in Breast Cancer

先前与乳腺癌有关的基因的基于人群的研究

2021-02-04473
OA